Teaching Student Support Tutor
Turnbull, A. Design and development of novel DNA Topoisomerase inhibitors. (Thesis)
Dias, N., Goossens, J., Baldeyrou, B., Lansiaux, A., Colson, P., Di Salvo, A., …Bailly, C. (2005). Oxoazabenzo[de]anthracenes conjugated to Amino Acids: Synthesis and evaluation as DNA-binding antitumor agents. Bioconjugate Chemistry. 16, 949 - 958. doi:10.1021/bc050065x. ISSN 1043-1802
We report the synthesis of an original series of oxoazabenzo[de]anthracenes conjugated to an amino acid: Ala, Phe, Pro, Lys, or Gly (4a-e, respectively). The compounds, derive...
Mincher, D. & Turnbull, A. (2004). Anthracene derivatives as anti-cancer agents.
The present invention relates to compounds which are based on an anthraquinone nucleus for use in medicine, particularly as anti-cancer agents which exert their effects throug...
OLUWADARE, E., REHAN, A., DING, Y., Turnbull, A., Malone, E., MINCHER, D., & PROUDFOOT, L. (2016, September). Development of mitochondria- and protease-specific prodrugs in the potential treatment of parasitic helminth infections. Poster presented at Molecular & Cellular Biology of Helminth Parasites X, Hydra, Greece
Anthelmintic resistance and the shortage of new drugs represent an urgent need for the development of novel anti-parasite drugs with effective delivery to the target site. Red...
Mathur, S., Mincher, D., Turnbull, A., Stevens, C. & Poole, A. (2016). Design and evaluation of novel theranostic fluorogenic dual probe-prodrug in cancer. European Journal of Cancer. 61, S142. doi:10.1016/s0959-8049(16)61501-0. ISSN 0959-8049
Background: In spite of major advances in the diagnosis and treatment of cancer, there remains a paucity of biomarkers for early detection. Legumain is a potential cancer biom...
The majority of clinically used anticancer drugs suffer from poor selectivity for tumour ...